background image

Paid Clinical Trials Overland Park

Discover 783 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Saruparib

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Westwood KS, Columbia MO, Wichita KS, Des Moines IAshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Rozanolixizumab

Recruiting
PHASE3

Sponsor:

UCB Biopharma SRL

Location:

Kansas City KS, Peoria IL, Rochester MN, Aurora COshow 10 more

Code:

NCT05063162

Conditions

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Rozanolixizumab

Placebo

Inotuzumab Ozogamicin

Recruiting
PHASE1
PHASE2

Sponsor:

Leland Metheny

Location:

Westwood KS, Omaha NE, Columbus OH, Cleveland OHshow 2 more

Code:

NCT03104491

Conditions

Acute Lymphocytic Leukemia

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Not accepted

Interventions

Inotuzumab Ozogamicin

Observational Study

Recruiting

Sponsor:

Texas Cardiac Arrhythmia Research Foundation

Location:

Kansas City KS, Austin TX

Code:

NCT04830774

Conditions

COVID-19

Atrial Fibrillation New Onset

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ILR, PMK, ICD

BIIB091 & DRF

Recruiting
PHASE2

Sponsor:

Biogen

Location:

Kansas City KS, Saint Louis MO, Cordova TN, Madison WIshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

Talquetamab, Daratumumab, Pomalidomide

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Westwood KS, Saint Louis MO, Little Rock AR, Memphis TNshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Acolbifene vs. Tamoxifen

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Kansas City KS, Chicago IL, Columbus OH, Duarte CA

Code:

NCT05941520

Conditions

Breast Atypical Hyperplasia

Breast Carcinoma

Breast Ductal Carcinoma In Situ

Breast Lobular Carcinoma In Situ

Eligibility Criteria

Sex: Female

Age: 35+

Healthy Volunteers: Not accepted

Interventions

Acolbifene Hydrochloride

Biospecimen Collection

Mammography

Random Periareolar Fine-Needle Aspiration

Tamoxifen

CVN424

Recruiting
PHASE3

Sponsor:

Cerevance

Location:

Kansas City KS, Tulsa OK, Memphis TN, Cincinnati OHshow 15 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

Losartan with Modulator

Recruiting
PHASE2

Sponsor:

University of Kansas Medical Center

Location:

Kansas City KS

Code:

NCT06364176

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Losartan

Placebo

Divalproex Sodium

Recruiting
PHASE1

Sponsor:

Vince & Associates Clinical Research, Inc.

Location:

Overland Park KS

Code:

NCT01898676

Conditions

Epilepsy

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Divalproex Sodium Extended-release 250mg

DEPAKOTE 250mg